Summary by Futu AI
NEW SHARP PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (“NEW SHARP PHARMACEUTICALS”) WILL HOLD A BOARD MEETING ON MONDAY, 25 MARCH 2024 TO CONSIDER AND APPROVE THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023 AND THEIR PUBLICATION. The meeting will also consider whether to pay a final dividend. The Executive Directors of XinQi Pharmaceuticals include Ms. Wang Qiu Qin, Mr. Ho Chi Hong, Mr. Xue Ping and Ms. Zhou Wan. The Independent Non-Executive Directors are Mr. Leung Chi Kin, Ms. Lee Sian Ming and Mr. Shi Lai Yin.